Why the study?
Does peripheral insulin treatment correct diabetes-induced alterations in myocardial lipid molecular species in a streptozotocin-induced diabetic rat model?
Does peripheral insulin treatment correct diabetes-induced alterations in myocardial lipid molecular species in a streptozotocin-induced diabetic rat model?
Peripheral insulin therapy alone may not be sufficient to correct all metabolic alterations, specifically triacylglycerol remodeling, present in diabetic myocardium.
No takes yet. Share an insight, caveat, or question.
Peripheral insulin may incompletely correct myocardial lipid alterations; leaves open adjunctive strategies targeting triacylglycerol remodeling.
Han et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: